Bailard, Inc. Insulet Corp Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$272.48 - $330.23 $7,629 - $9,246	-28 Reduced 2.9%	937 $270,000
Q1 2023 May 08, 2023	BUY	$276.36 - $326.03 $1,105 - $1,304	4 Added 0.42%	965 $307,000
Q4 2022 Feb 02, 2023	BUY	$212.22 - $313.46 $1,273 - $1,880	6 Added 0.63%	961 $282,000
Q3 2022 Oct 18, 2022	BUY	$224.6 - $281.45 $4,492 - $5,629	20 Added 2.14%	955 $219,000
Q2 2022 Jul 27, 2022	SELL	$186.4 - $279.02 $106,248 - $159,041	-570 Reduced 37.87%	935 $204,000
Q1 2022 Apr 25, 2022	BUY	$194.8 - $275.7 $293,174 - $414,928	1,505 New	1,505 $401,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.